 |
 |

Antihyperglycemic Therapy for Patients With Renal Failure
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: In their Clinical Applications article about the initial dose of a basal-prandial insulin regimen, Drs DeWitt and Dugdale1 did not mention the importance of assessing renal function. Insulin duration of action is increased in renal insufficiency as a result of decreased renal insulin degradation and clearance.2 In addition, renal gluconeogenesis may be impaired, possibly due to limitation of the amino acid substrate alanine.3 Furthermore, many patients with renal failure have decreased caloric intake due to the accompanying anorexia. Indeed, insulin therapy and renal dysfunction have been reported to be the 2 most frequent diagnoses associated with hypoglycemia in hospitalized patients.4 Unfortunately, similar data from outpatients are lacking, in part because of exclusion of patients with various degrees of renal failure from diabetes clinical trials.
In our experience, renal insufficiency is an important factor that predisposes patients with diabetes to iatrogenic hypoglycemia. This is true in those receiving . . . [Full Text of this Article]
Nasser Mikhail, MD, MSc
Endocrinology Division
Dennis Cope, MD
Medicine Department Olive-View-UCLA Medical Center Sylmar, Calif
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
Antihyperglycemic Therapy for Patients With Renal FailureReply
Dawn E. DeWitt and David C. Dugdale
JAMA. 2003;290(8):1027.
EXTRACT
| FULL TEXT
Using New Insulin Strategies in the Outpatient Treatment of Diabetes: Clinical Applications
Dawn E. DeWitt and David C. Dugdale
JAMA. 2003;289(17):2265-2269.
ABSTRACT
| FULL TEXT
|